corgenix Message Board - Msg: 24465485

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : corgenix

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: RikRichter	4/3/2008 12:55:40 PM
	of 191

Corgenix Makes Deal with UK Company Denver Business Journal Thursday, April 3, 2008 10:00 AM MDT Corgenix Medical Corp. will work with a United Kingdom company to expand test processing technology and distribution of its Corgenix AspirinWorks product. Broomfield-based Corgenix (OTCBB: CONX) develops and markets diagnostic test kits for vascular diseases, immunology disorders, and bone and joint disorders. It reported Thursday that it's made an agreement with Randox Laboratories, a diagnostic company with headquarters in Crumlin, UK. The AspirinWorks test will be manufactured at Randox, and the two companies will share global distribution rights. AspirinWorks is a urine test that measures the effect of aspirin on platelets. All contents of this site © American City Business Journals Inc. All rights reserved.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next